"Yes, agree (but imagine the API situation with positive COVID data)."
I fear a very positive COVID outcome for that reason along with the impact such a worldwide need would have on any chance that Amarin could hold exclusivity on the product. There would be an almost immediate ramp up of production sponsored by various countries that would flood the market with EPA. I can assure you that encapsulating a product that is identical to Vascepa would be a complete cake-walk compared to the efforts required to develop effective vaccines. Amarin would be one of many selling a commodity that is extremely cheap and ubiquitous.
News 
Market Data 
Discover 
AI
